Comparing Photon and Charged Particle Therapy Using DNA Damage Biomarkers

Area of Science:

• Oncology
• Radiation Oncology
• Radiobiology

Background:

• Cancer radiation therapy is diversifying with photon, proton, and carbon-ion modalities.
• Understanding high-LET (high linear energy transfer) radiobiology is crucial for charged particle therapy.
• DNA damage response is a key factor in radiation therapy efficacy.

Purpose of the Study:

• To provide a comprehensive summary and comparison of photon, proton, and carbon-ion therapy.
• To focus on DNA damage biomarkers for monitoring therapy effectiveness.
• To analyze dose distribution and mechanisms of action from nucleic acid to cell death.

Main Methods:

• Literature review of cancer radiation therapy modalities.
• Comparison of treatment profiles based on DNA damage biomarkers.
• Analysis of dose distribution and biological effects.

Main Results:

• Photon, proton, and carbon-ion therapies exhibit distinct dose distributions and biological effects.
• High-LET radiation, like proton and carbon-ion therapy, shows unique DNA damage response patterns.
• DNA damage biomarkers are effective in monitoring and comparing therapy outcomes.

Conclusions:

• Charged particle therapy (proton and carbon-ion) offers advanced treatment options requiring a deep understanding of radiobiology.
• Optimization of charged particle radiation therapy relies on monitoring DNA damage response.
• Further research into high-LET radiobiology can enhance cancer treatment strategies.